VivoSeq
Other

Breastfeeding

0

Pipeline Programs↗

6

Active Trials↗

4

Companies Involved↗

Breastfeeding is an early-stage landscape with 0 programs across 4 companies. The most active players are Pfizer, Novo Nordisk, Biogen.

Intelligence

Pipeline Metrics

Competitive Density

21/100

Pipeline Velocity

19/100

Mech. Concentration

N/A

Completion Rate

96/100

Attrition Rate

3/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Pfizer logo

Pfizer

0 programs

PreclinicalNovo Nordisk logo

Novo Nordisk

0 programs

PreclinicalBiogen logo

Biogen

0 programs

PreclinicalD

Dilek Kucuk Alemdar

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

34

clinical trials

Completed25 · 74%
Recruiting3 · 9%
Active, not recruiting3 · 9%
Unknown status2 · 6%
Withdrawn1 · 3%

Clinical Trials

Trial Activity

34 trials

A Study to Learn How the Study Medicine Called Etrasimod is Taken up Into Blood and Breastmilk of Healthy Breastfeeding Women
Recruiting·Pfizer logoPfizer·Phase 1·NCT07153159·8 enrolled
Postpartum Vaginal Estrogen for Breastfeeding Patients
Recruiting·UUniversity Hospitals Cleveland Medical Center·Phase 4·NCT05457972·100 enrolled
The Effect of Podcast Breastfeeding Training on Breastfeeding Outcomes of Mothers of Preterm Infants Hospitalized in the Neonatal Intensive Care Unit (NICU): A Randomized Controlled Study
Recruiting·—·Preclinical·NCT07660965·56 enrolled
Tshireletso: Safety, Efficacy and Feasibility of Cabotegravir-LA PrEP in a Breastfeeding Population in Botswana
Active, not recruiting·—·Phase 4·NCT05986084·500 enrolled
The Effect Of Postpartum Therapeutıc Touch On Breastfeedıng Self-Effıcacy, Maternal Attachment, And Postpartum Depressıon In Prımıparous Women: A Randomızed Controlled Study
Active, not recruiting·NNecmettin Erbakan University·Preclinical·NCT07693010·72 enrolled
IMPAC: Integrated Maternal Postpartum Appointment Combination in Mayo Clinic Health System Northwest Wisconsin
Active, not recruiting·MMayo Clinic·Preclinical·NCT06395168·246 enrolled
Using Nevirapine to Prevent Mother-to-Child HIV Transmission During Breastfeeding
Completed·National Institute of Allergy and Infectious Diseases (NIAID)·Phase 3·NCT00074412·2,026 enrolled
Effect of Lanolin and Breastmilk in the Treatment of Sore and Damaged Nipples in Breastfeeding Women
Completed·UUniversity of Mostar·Phase 2·NCT04153513·206 enrolled
Timing of Postpartum Depot Medroxyprogesterone Acetate Administration on Breastfeeding, Contraceptive Continuation, and Depression
Completed·—·Phase 4·NCT01463202·184 enrolled
A Study of Zidovudine/Lamivudine and Either Nevirapine or Nelfinavir for Reduction of Mother-to-child HIV Transmission During Breastfeeding
Completed·Centers for Disease Control and Prevention·Phase 2·NCT00146380·520 enrolled
The Effect of Neuraxial Analgesia on Maternal Breastfeeding
Completed·NNorthwestern University·N/A·NCT01074190·345 enrolled
Safety and Drug Detection Study of Dapivirine Vaginal Ring and Oral TRUVADA® in Breastfeeding Mother-Infant Pairs
Completed·National Institute of Allergy and Infectious Diseases (NIAID)·Phase 3·NCT04140266·394 enrolled
Breastfeeding Etonogestrel Implant Study
Completed·UUniversity of New Mexico·Phase 4·NCT03978598·150 enrolled
Evaluation of Pre-exposure Prophylaxis Cascade in Pregnant and Breastfeeding Women in Cape Town (Formative Study)
Completed·UUniversity of California, Los Angeles·Phase 4·NCT03826199·200 enrolled
PrEP in Breastfeeding Study
Completed·UUniversity of Washington·Phase 2/3·NCT02776748·50 enrolled
Page 1 of 3

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)